Are we ready to prescribe a polypill to our patients?

The all-in-one pill combination (Polypill) of several active components used in primary prevention of cardiovascular disease was a decade ago purposed to reduce the cardiovascular burden by more than 80%. This Polypill could be approved before 2013 in United States. Although controversed, it could a...

Full description

Bibliographic Details
Published in:Revue medicale suisse, Vol. 8, No. 360 (2012), p. 2046, 2048-51
Main Author: Castioni, J
Other Involved Persons: Mooser, V ; Waeber, G
Format: Article
Language:French
ISSN:1660-9379
Item Description:Date Completed 09.01.2013
Date Revised 27.11.2012
published: Print
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Subjects:
QR Code: Show QR Code
Description:
  • The all-in-one pill combination (Polypill) of several active components used in primary prevention of cardiovascular disease was a decade ago purposed to reduce the cardiovascular burden by more than 80%. This Polypill could be approved before 2013 in United States. Although controversed, it could answer to the worried situation even observed in Switzerland: the adherence to secondary prevention treatments is clearly insufficient and the cardiovascular events remain in the first row of death's causes. This abstract summarize the results from interventional studies who tried to valid this concept as well as the main stakes to be assessed on the medical side before to consider such a similar approach in Switzerland